117 related articles for article (PubMed ID: 7934163)
1. The incidence and prognostic significance of mutations in codon 13 of the N-ras gene in acute myeloid leukemia.
Coghlan DW; Morley AA; Matthews JP; Bishop JF
Leukemia; 1994 Oct; 8(10):1682-7. PubMed ID: 7934163
[TBL] [Abstract][Full Text] [Related]
2. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implication of N-RAS gene mutations in Egyptian adult acute myeloid leukemia.
Elghannam DM; Abousamra NK; Shahin DA; Goda EF; Azzam H; Azmy E; El-Din MS; El-Refaei MF
Egypt J Immunol; 2009; 16(1):9-15. PubMed ID: 20726318
[TBL] [Abstract][Full Text] [Related]
4. Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas.
Koulos JP; Wright TC; Mitchell MF; Silva E; Atkinson EN; Richart RM
Gynecol Oncol; 1993 Mar; 48(3):364-9. PubMed ID: 8385060
[TBL] [Abstract][Full Text] [Related]
5. 12th codon mutation resulting in c-N-ras activation in acute myelogenous leukemia.
Needleman SW; Devine SE; Kraus MH
Leukemia; 1988 Feb; 2(2):91-3. PubMed ID: 3278172
[TBL] [Abstract][Full Text] [Related]
6. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
7. Analysis of ras gene mutations in acute myeloid leukemia by the polymerase chain reaction and oligonucleotide probes.
Chin YM; Bosco JJ; Koh CL
Singapore Med J; 1992 Feb; 33(1):48-50. PubMed ID: 1598607
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia.
Marková J; Michková P; Burčková K; Březinová J; Michalová K; Dohnalová A; Maaloufová JS; Soukup P; Vítek A; Cetkovský P; Schwarz J
Eur J Haematol; 2012 Feb; 88(2):128-35. PubMed ID: 21967546
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.
Renneville A; Boissel N; Nibourel O; Berthon C; Helevaut N; Gardin C; Cayuela JM; Hayette S; Reman O; Contentin N; Bordessoule D; Pautas C; Botton Sd; Revel Td; Terre C; Fenaux P; Thomas X; Castaigne S; Dombret H; Preudhomme C
Leukemia; 2012 Jun; 26(6):1247-54. PubMed ID: 22289988
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia.
Lübbert M; Mirro J; Kitchingman G; McCormick F; Mertelsmann R; Herrmann F; Koeffler HP
Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347
[TBL] [Abstract][Full Text] [Related]
11. Ras point mutations occur in acute myeloid leukemia with illegitimate T-cell receptor delta gene rearrangement.
Schmidt CA; Przybylski G; Vogel D; Ludwig WD; Oettle H; Neubauer A; Siegert W
Leukemia; 1994 Jan; 8(1):102-5. PubMed ID: 8289473
[TBL] [Abstract][Full Text] [Related]
12. RAS and FMS mutations following cytotoxic therapy for childhood acute lymphoblastic leukaemia.
Taylor C; McGlynn H; Carter G; Baker AH; Warren N; Ridge SA; Owen G; Thompson E; Thompson PW; Jacobs A
Leukemia; 1995 Mar; 9(3):466-70. PubMed ID: 7885045
[TBL] [Abstract][Full Text] [Related]
13. Direct sequencing of amplified genomic fragments documents N-ras point mutations in myeloid leukemia.
Collins SJ
Oncogene Res; 1988 Sep; 3(2):117-23. PubMed ID: 3067186
[TBL] [Abstract][Full Text] [Related]
14. Frequency of RAS gene mutation and its cooperative genetic events in Southeast Asian adult acute myeloid leukemia.
Auewarakul CU; Lauhakirti D; Tocharoentanaphol C
Eur J Haematol; 2006 Jul; 77(1):51-6. PubMed ID: 16573741
[TBL] [Abstract][Full Text] [Related]
15. Low frequency of ras oncogene mutations in Philadelphia-positive acute leukemia and report of a novel mutation H61 Leu in a single case.
Urbano-Ispizua A; Gill R; Matutes E; Levi S; Wiedemann LM; Catovsky D; Marshall CJ
Leukemia; 1992 Apr; 6(4):342-6. PubMed ID: 1588796
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of K-ras codon 12 in blood samples of patients with acute myeloid leukemia.
Preston R; Däbritz J; Hänfler J; Oettle H
Leuk Res; 2010 Jul; 34(7):883-91. PubMed ID: 20304488
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.
Green CL; Koo KK; Hills RK; Burnett AK; Linch DC; Gale RE
J Clin Oncol; 2010 Jun; 28(16):2739-47. PubMed ID: 20439648
[TBL] [Abstract][Full Text] [Related]
18. ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis.
Sugio K; Ishida T; Yokoyama H; Inoue T; Sugimachi K; Sasazuki T
Cancer Res; 1992 May; 52(10):2903-6. PubMed ID: 1581907
[TBL] [Abstract][Full Text] [Related]
19. A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients.
Hatzaki A; Razi E; Anagnostopoulou K; Iliadis K; Kodaxis A; Papaioannou D; Labropoulos S; Vasilaki M; Kosmidis P; Saetta A; Mihalatos M; Nasioulas G
Mol Cell Probes; 2001 Oct; 15(5):243-7. PubMed ID: 11735295
[TBL] [Abstract][Full Text] [Related]
20. K-Ras mutations and N-Ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangements.
Liang DC; Shih LY; Fu JF; Li HY; Wang HI; Hung IJ; Yang CP; Jaing TH; Chen SH; Liu HC
Cancer; 2006 Feb; 106(4):950-6. PubMed ID: 16404744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]